Tenax Therapeutics Stock Market Value
| TENX Stock | USD 5.72 0.36 6.72% |
| Symbol | Tenax |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tenax Therapeutics. If investors know Tenax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tenax Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Tenax Therapeutics is measured differently than its book value, which is the value of Tenax that is recorded on the company's balance sheet. Investors also form their own opinion of Tenax Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Tenax Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tenax Therapeutics' market value can be influenced by many factors that don't directly affect Tenax Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tenax Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Tenax Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tenax Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Tenax Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Tenax Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Tenax Therapeutics.
| 12/09/2023 |
| 12/03/2024 |
If you would invest 0.00 in Tenax Therapeutics on December 9, 2023 and sell it all today you would earn a total of 0.00 from holding Tenax Therapeutics or generate 0.0% return on investment in Tenax Therapeutics over 360 days. Tenax Therapeutics is related to or competes with Allarity Therapeutics, Neurobo Pharmaceuticals, Virax Biolabs, Quoin Pharmaceuticals, Revelation Biosciences, ZyVersa Therapeutics, and Sonnet Biotherapeutics. Tenax Therapeutics, Inc., a specialty pharmaceutical company, engages in identifying, developing, and commercializing pr... More
Tenax Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Tenax Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Tenax Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.73 | |||
| Information Ratio | 0.1674 | |||
| Maximum Drawdown | 18.78 | |||
| Value At Risk | (4.48) | |||
| Potential Upside | 6.72 |
Tenax Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Tenax Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Tenax Therapeutics' standard deviation. In reality, there are many statistical measures that can use Tenax Therapeutics historical prices to predict the future Tenax Therapeutics' volatility.| Risk Adjusted Performance | 0.1633 | |||
| Jensen Alpha | 0.6327 | |||
| Total Risk Alpha | 0.1757 | |||
| Sortino Ratio | 0.2106 | |||
| Treynor Ratio | 1.39 |
Tenax Therapeutics Backtested Returns
Tenax Therapeutics appears to be slightly risky, given 3 months investment horizon. Tenax Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.2, which indicates the firm had a 0.2% return per unit of risk over the last 3 months. By inspecting Tenax Therapeutics' technical indicators, you can evaluate if the expected return of 0.7% is justified by implied risk. Please review Tenax Therapeutics' Coefficient Of Variation of 491.12, risk adjusted performance of 0.1633, and Semi Deviation of 2.33 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Tenax Therapeutics holds a performance score of 16. The entity has a beta of 0.5, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Tenax Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Tenax Therapeutics is expected to be smaller as well. Please check Tenax Therapeutics' potential upside, as well as the relationship between the accumulation distribution and price action indicator , to make a quick decision on whether Tenax Therapeutics' existing price patterns will revert.
Auto-correlation | -0.61 |
Very good reverse predictability
Tenax Therapeutics has very good reverse predictability. Overlapping area represents the amount of predictability between Tenax Therapeutics time series from 9th of December 2023 to 6th of June 2024 and 6th of June 2024 to 3rd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Tenax Therapeutics price movement. The serial correlation of -0.61 indicates that roughly 61.0% of current Tenax Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.61 | |
| Spearman Rank Test | -0.75 | |
| Residual Average | 0.0 | |
| Price Variance | 0.38 |
Tenax Therapeutics lagged returns against current returns
Autocorrelation, which is Tenax Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Tenax Therapeutics' stock expected returns. We can calculate the autocorrelation of Tenax Therapeutics returns to help us make a trade decision. For example, suppose you find that Tenax Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Tenax Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Tenax Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Tenax Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Tenax Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Tenax Therapeutics Lagged Returns
When evaluating Tenax Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Tenax Therapeutics stock have on its future price. Tenax Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Tenax Therapeutics autocorrelation shows the relationship between Tenax Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Tenax Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Tenax Stock Analysis
When running Tenax Therapeutics' price analysis, check to measure Tenax Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tenax Therapeutics is operating at the current time. Most of Tenax Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tenax Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tenax Therapeutics' price. Additionally, you may evaluate how the addition of Tenax Therapeutics to your portfolios can decrease your overall portfolio volatility.